|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 1 (July 1), 1999:
pp. 186-191
Kozak Sequence Polymorphism of the Glycoprotein (GP) Ib Gene Is a
Major Determinant of the Plasma Membrane Levels of the Platelet GP
Ib-IX-V Complex
Vahid Afshar-Kharghan,
Chester Q. Li,
Mohammad Khoshnevis-Asl, and
José A. López
From the Departments of Medicine and Molecular and Human Genetics,
Baylor College of Medicine and Veterans Affairs Medical Center,
Houston, TX.
Despite the known importance of the sequences surrounding ATG start
codons (Kozak sequences) for efficient translation of proteins, few
reports have appeared that describe the natural variations in these
sequences. Here, we report a human polymorphism in the Kozak sequence
of the platelet adhesion receptor, glycoprotein (GP) Ib , a component
of the GP Ib-IX-V complex, which mediates the initial adhesion of
platelets to the blood vessel wall following injury. The polymorphism
is based on the presence of either thymine (T) or cytosine (C) at
position 5 from the initiator ATG in the GP Ib gene. The less
common allele, 5C, represented 8% to 17% of the alleles in four
ethnic populations surveyed. This allele more closely resembles the
sequence considered optimal for efficient initiation of protein
translation and is associated with increased expression of the receptor
on the cell membrane, both in transfected cells and in the platelets of
individuals carrying the allele. In vitro transcription/translation
studies indicate that the increased expression results from more
efficient translation of the 5C form of the GP Ib mRNA. Other
mutations made to approximate more closely the consensus sequence
described by Kozak did not increase expression of the receptor. This is
the first known description of Kozak sequence polymorphism as a
determinant of the surface levels of a cell adhesion receptor. This
polymorphism may influence an individual's susceptibility for the
development of cardiovascular disease.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. I. Jones, S. Bray, S. F. Garner, J. Stephens, B. de Bono, W. G. J. Angenent, D. Bentley, P. Burns, A. Coffey, P. Deloukas, et al.
A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways
Blood,
August 13, 2009;
114(7):
1405 - 1416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Maguire, A. Thakkinstian, J. Sturm, C. Levi, L. Lincz, M. Parsons, S. Whyte, and J. Attia
Polymorphisms in Platelet Glycoprotein 1b{alpha} and Factor VII and Risk of Ischemic Stroke: A Meta-Analysis
Stroke,
June 1, 2008;
39(6):
1710 - 1716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Bray, T. D. Howard, E. Vittinghoff, D. C. Sane, and D. M. Herrington
Effect of genetic variations in platelet glycoproteins Ib{alpha} and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy
Blood,
March 1, 2007;
109(5):
1862 - 1869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ohmori, J. Mimuro, K. Takano, S. Madoiwa, Y. Kashiwakura, A. Ishiwata, M. Niimura, K. Mitomo, T. Tabata, M. Hasegawa, et al.
Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ib{alpha} promoter: in vivo model for platelet-targeting gene therapy
FASEB J,
July 1, 2006;
20(9):
1522 - 1524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. V. Vijayan and P. F. Bray
Molecular Mechanisms of Prothrombotic Risk Due to Genetic Variations in Platelet Genes: Enhanced Outside-In Signaling Through the Pro33 Variant of Integrin {beta}3.
Experimental Biology and Medicine,
May 1, 2006;
231(5):
505 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mikkelsson, M. Perola, and P. J. Karhunen
Genetics of Platelet Glycoprotein Receptors: Risk of Thrombotic Events and Pharmacogenetic Implications
Clinical and Applied Thrombosis/Hemostasis,
April 1, 2005;
11(2):
113 - 125.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Stratmann and D. Tschoepe
Pathobiology and cell interactions of platelets in diabetes
Diabetes and Vascular Disease Research,
February 1, 2005;
2(1):
16 - 23.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Kunicki, A. B. Federici, D. R. Salomon, J. A. Koziol, S. R. Head, T. S. Mondala, J. D. Chismar, L. Baronciani, M. T. Canciani, and I. R. Peake
An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees
Blood,
October 15, 2004;
104(8):
2359 - 2367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-T. Li, S. Larrucea, S. Souza, S. M. Leal, J. A. Lopez, E. M. Rubin, B. Nieswandt, and P. F. Bray
Genetic variation responsible for mouse strain differences in integrin {alpha}2 expression is associated with altered platelet responses to collagen
Blood,
May 1, 2004;
103(9):
3396 - 3402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Best, Y. A. Senis, G. E. Jarvis, H. J. Eagleton, D. J. Roberts, T. Saito, S. M. Jung, M. Moroi, P. Harrison, F. R. Green, et al.
GPVI levels in platelets: relationship to platelet function at high shear
Blood,
October 15, 2003;
102(8):
2811 - 2818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Macchi, L. Christiaens, S. Brabant, N. Sorel, S. Ragot, J. Allal, G. Mauco, and A. Brizard
Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T kozak (GP Ib{alpha}) polymorphisms
J. Am. Coll. Cardiol.,
September 17, 2003;
42(6):
1115 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ulrichts, K. Vanhoorelbeke, S. Cauwenberghs, S. Vauterin, H. Kroll, S. Santoso, and H. Deckmyn
Von Willebrand Factor But Not {alpha}-Thrombin Binding to Platelet Glycoprotein Ib{alpha} Is Influenced by the HPA-2 Polymorphism
Arterioscler Thromb Vasc Biol,
July 1, 2003;
23(7):
1302 - 1307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Park, S. H. Park, J. E. Choi, S. Y. Lee, H.-S. Jeon, S. I. Cha, C. H. Kim, J.-H. Park, S. Kam, R. W. Park, et al.
Polymorphisms of the DNA Repair Gene Xeroderma Pigmentosum Group A and Risk of Primary Lung Cancer
Cancer Epidemiol. Biomarkers Prev.,
October 1, 2002;
11(10):
993 - 997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Kunicki
The Influence of Platelet Collagen Receptor Polymorphisms in Hemostasis and Thrombotic Disease
Arterioscler Thromb Vasc Biol,
January 1, 2002;
22(1):
14 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Douglas, K Michaelides, D A Gorog, E Durante-Mangoni, N Ahmed, G J Davies, and E G D Tuddenham
Platelet membrane glycoprotein Ib{alpha} gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis
Heart,
January 1, 2002;
87(1):
70 - 74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Cadroy, K. S. Sakariassen, J.-P. Charlet, C. Thalamas, B. Boneu, and P. Sie
Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men
Blood,
November 15, 2001;
98(10):
3159 - 3161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Meisel, V. Afshar-Kharghan, I. Cascorbi, M. Laule, V. Stangl, S. B. Felix, G. Baumann, J. A. Lopez, I. Roots, and K. Stangl
Role of Kozak sequence polymorphism of platelet glycoprotein Ib{alpha} as a risk factor for coronary artery disease and catheter interventions
J. Am. Coll. Cardiol.,
October 1, 2001;
38(4):
1023 - 1027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. I. Baker, J. Eikelboom, E. Lofthouse, N. Staples, V. Afshar-Kharghan, J. A. Lopez, Y. Shen, M. C. Berndt, and G. Hankey
Platelet glycoprotein Ib{alpha} Kozak polymorphism is associated with an increased risk of ischemic stroke
Blood,
July 1, 2001;
98(1):
36 - 40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Williams and P. F. Bray
Genetics of Arterial Prothrombotic Risk States
Experimental Biology and Medicine,
May 1, 2001;
226(5):
409 - 419.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. B. Frank, A. P. Reiner, S. M. Schwartz, P. N. Kumar, R. M. Pearce, P. G. Arbogast, W. T. Longstreth Jr, F. R. Rosendaal, B. M. Psaty, and D. S. Siscovick
The Kozak sequence polymorphism of platelet glycoprotein Ib{alpha} and risk of nonfatal myocardial infarction and nonfatal stroke in young women
Blood,
February 15, 2001;
97(4):
875 - 879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Samani, J. A. Lopez, and V. Afshar-Kharghan
Kozak sequence polymorphism in the platelet GPIb{alpha} gene is not associated with risk of myocardial infarction
Blood,
March 15, 2000;
95(6):
2183 - 2184.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sonoda, M. Murata, D. Ito, N. Tanahashi, A. Ohta, Y. Tada, E. Takeshita, T. Yoshida, I. Saito, M. Yamamoto, et al.
Association Between Platelet Glycoprotein Ib{alpha} Genotype and Ischemic Cerebrovascular Disease
Stroke,
February 1, 2000;
31(2):
493 - 497.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|